HUMA Therapeutics: Bayer Partners with Huma on Bayer® Aspirin Heart Risk Assessment Online Educational Tool to Raise Awareness of Heart Health and its Risk Factors

Huma's predictive algorithm will power a new global online patient engagement tool* that provides an accessible solution for heart health education NEW YORK, Feb. 1, 2023 /PRNewswire/

Related Keywords

Nicole Hayes ,Dan Vahdat ,Christin Miller ,Reese Fitzpatrick ,Schwierige Zeiten ,Instagram ,Prnewswire Huma Therapeutics Limited ,Pr Communications ,Twitter ,Facebook ,Journal Of Medical Internet Research ,Therapeutics Limited ,Aspirin Heart Risk Assessment ,United Kingdom ,Heart Risk Assessment ,Heart Month ,Bayer Aspirin ,Risk Assessment ,Bayer Aspirin Risk Assessment ,Medical Device ,Medical Internet ,Huma ,Herapeutics ,Player ,Partners ,Uma ,Aspirin ,Heart ,Risk ,Assessment ,Nline ,Educational ,Tool ,Raise ,Awareness ,Health ,Actors ,